Mode
Home
Conditions Medications Drug Pipeline Weekly Digests Questions
Text Size
Log in / Sign up
Home › Questions › Pulmonology & Critical Care

Can exhaled breath tests like AveloMask replace lung swabs for pneumonia?

moderate confidence  ·  Last reviewed May 11, 2026

Exhaled breath tests like the AveloMask offer a non-invasive way to detect pneumonia-causing germs. A 2025 study found that the AveloMask correctly identified the main pathogen in 85% of cases, but it missed some low-abundance or co-infecting organisms. For now, lung swabs (sputum or BAL) remain the standard because they are more sensitive for all pathogens present.

What the research says

A prospective study of 63 hospitalized adults with pneumonia compared AveloMask exhaled breath aerosol (XBA) samples to lower respiratory tract (LRT) specimens (sputum or BAL) 4. The AveloMask identified the dominant pathogen (the one with the lowest Ct value in the LRT sample) in 40 out of 47 LRT-positive cases, giving a positive percent agreement (PPA) of 85.1% 4. However, when looking at all detected targets, the PPA was 61% (95% CI, 50-72%), meaning the AveloMask missed some pathogens, especially low-abundance or co-infecting ones 4. The negative percent agreement (NPA) was 100% (95% CI, 99-100%), so when the AveloMask said a germ was absent, it was almost always correct 4. The overall percent agreement (OPA) was 95% (95% CI, 92-96%) 4. The study concluded that AveloMask sampling is a promising non-invasive tool, but its lower sensitivity for some pathogens means it cannot yet replace LRT sampling for comprehensive diagnosis 4. Other sources do not directly address exhaled breath tests for pneumonia, but they highlight the importance of accurate pathogen identification: a systematic review in Ghana found Streptococcus pneumoniae as the most common cause, with high antibiotic resistance 1, and a Kenyan study noted that current diagnostic tools are not accurate enough to avoid unnecessary antibiotics 6.

What to ask your doctor

  • Is the AveloMask test available at your hospital, and if so, when might it be appropriate to use instead of a sputum or BAL sample?
  • If I have a negative AveloMask result, would you still recommend a lung swab to rule out low-abundance or co-infecting pathogens?
  • How does the AveloMask's 85% detection rate for the main pathogen compare to the standard tests you use for pneumonia?
  • Are there any studies that have tested the AveloMask in patients like me (e.g., with specific risk factors or severity)?

This question is drawn from common patient questions about Pulmonology & Critical Care and answered using cited medical research. We do not provide individualized advice.